Clinical Trials · NCT06463457

Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)

Name: Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

Active Not RecruitingPhase 2Gonadorelin

Phase: Phase 2
Recruitment status: Active Not Recruiting
Sponsor: Atish Choudhury, MD
Enrollment: 33
Start date: Dec 2024
Locations: 3 sites, United States
Primary endpoint: 18-month Rate of Testosterone Recovery

View Gonadorelin compound reference